Peter Schirmacher

发表

Kristina Schwamborn, Mark Kriegsmann, Wilko Weichert, 2018, Proteomics.

Variant classification in precision oncology

Melanie Boerries, Olaf Neumann, Michael Thomas, 2019, International journal of cancer.

Vascular Biomaterial Banking in Academia

Peter Schirmacher, Dittmar Böckler, Maani Hakimi, 2019, European Surgical Research.

Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience.

Melanie Boerries, Mario Lamping, Damian T. Rieke, 2018, JCO precision oncology.

Prognostic Impact and Clinicopathological Correlations of the Cribriform Pattern in Pulmonary Adenocarcinoma

Wilko Weichert, Arne Warth, Albrecht Stenzinger, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Site‐to‐Site Reproducibility and Spatial Resolution in MALDI–MSI of Peptides from Formalin‐Fixed Paraffin‐Embedded Samples

Kristina Schwamborn, Mark Kriegsmann, Wilko Weichert, 2019, Proteomics. Clinical applications.

Estimation of Immune Cell Densities in Immune Cell Conglomerates: An Approach for High-Throughput Quantification

Niels Grabe, Peter Schirmacher, Niels Halama, 2009, PloS one.

MicroRNA gene expression profile of hepatitis C virus–associated hepatocellular carcinoma

Peter Schirmacher, Margarete Odenthal, P. Schirmacher, 2007, Hepatology.

Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer.

Arne Warth, Kai Breuhahn, Peter Schirmacher, 2009, Cancer research.

The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.

Michael Thomas, Jan Budczies, Wilko Weichert, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma.

Frank Bergmann, Matthias Evert, Kai Breuhahn, 2013, Gastroenterology.

Oncogenic and tumor suppressive roles of polo‐like kinases in human hepatocellular carcinoma

Matthias Evert, Peter Schirmacher, Thomas Longerich, 2010, Hepatology.

The 2019 WHO classification of tumours of the digestive system

Peter Schirmacher, Ian A Cree, Fatima Carneiro, 2019, Histopathology.

Genome‐wide methylation screen in low‐grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis

Michael Rehli, Markus Brugger, Dieter Weichenhan, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Individualized medicine and demographic change as determining workload factors in pathology: quo vadis?

Wilko Weichert, Arne Warth, Albrecht Stenzinger, 2015, Virchows Archiv.

Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors

Olaf Neumann, Miriam Kesselmeier, Peter Schemmer, 2012, Hepatology.

Oncogenetic tree modeling of human hepatocarcinogenesis

Axel Benner, Kai Breuhahn, Peter Schirmacher, 2011 .

Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real‐life analysis of three larger gene panels

Olaf Neumann, Michael Thomas, Ivo Buchhalter, 2019, International journal of cancer.

Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis

Olaf Neumann, Michael Thomas, Ivo Buchhalter, 2018, International journal of cancer.

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer

Jürgen Weitz, Frank Bergmann, Jürgen Debus, 2012, Radiation oncology.

Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing.

Volker Endris, Wilko Weichert, Arne Warth, 2013, The Journal of molecular diagnostics : JMD.

Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease

Peter Schemmer, Peter Schirmacher, Peter Sauer, 2013, Clinical transplantation.

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

Chris Day, Fritz Wrba, Debbie Lawlor, 2016, Alimentary pharmacology & therapeutics.

AP-1-controlled hepatocyte growth factor activation promotes keratinocyte migration via CEACAM1 and urokinase plasminogen activator/urokinase plasminogen receptor.

Roland Eils, Kai Breuhahn, Peter Schirmacher, 2009, The Journal of investigative dermatology.

Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation

Hong Jiang, Peter Schirmacher, Han-Woong Lee, 2006, Nature Genetics.

Large‐scale comparative analyses of immunomarkers for diagnostic subtyping of non‐small‐cell lung cancer biopsies

Wilko Weichert, Arne Warth, Peter Schirmacher, 2012, Histopathology.

Targeted next‐generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance

Jan Budczies, Nicole Pfarr, Volker Endris, 2017, Genes, chromosomes & cancer.

Intrinsic breast cancer subtypes defined by estrogen receptor signalling—prognostic relevance of progesterone receptor loss

Petra Seibold, Andreas Schneeweiss, Jenny Chang-Claude, 2013, Modern Pathology.

Loss of aquaporin-4 expression and putative function in non-small cell lung cancer

Arne Warth, Peter Schirmacher, Andreas Buness, 2011, BMC Cancer.

Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis.

Gunda Millonig, Peter Schirmacher, Thomas Longerich, 2010, World journal of gastroenterology.

Molecular Profiling of Human Hepatocellular Carcinoma Defines Mutually Exclusive Interferon Regulation and Insulin-Like Growth Factor II Overexpression

Kai Breuhahn, Peter Schirmacher, Brian B Haab, 2004, Cancer Research.

Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue

Peter Schirmacher, Niels Halama, Matthias Kloor, 2013, Cancer Immunology, Immunotherapy.

Posttranscriptional destabilization of the liver‐specific long noncoding RNA HULC by the IGF2 mRNA‐binding protein 1 (IGF2BP1)

Sevim Ozgur, Kai Breuhahn, Peter Schirmacher, 2013, Hepatology.

Pathology and Biopsy Assessment of Non-Alcoholic Fatty Liver Disease

Peter Schirmacher, P. Schirmacher, B. Straub, 2010, Digestive Diseases.

Hepatocyte growth factor/hepatopoietin A is expressed in fat‐storing cells from rat liver but not myofibroblast‐like cells derived from fat‐storing cells

Peter Schirmacher, Antonello Pietrangelo, P. Schirmacher, 1992, Hepatology.

Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas

Roland Eils, Thomas Wolf, Volker Hovestadt, 2013, Genome Biology.

Copy number changes of clinically actionable genes in melanoma, non‐small cell lung cancer and colorectal cancer—A survey across 822 routine diagnostic cases

Daniel Heim, Nicole Pfarr, Volker Endris, 2016, Genes, chromosomes & cancer.

Liver specific overexpression of platelet‐derived growth factor‐B accelerates liver cancer development in chemically induced liver carcinogenesis

Thorsten Maass, Peter Schirmacher, Thomas Longerich, 2011, International journal of cancer.

Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.

Axel Benner, Peter Schirmacher, Magnus von Knebel Doeberitz, 2012, The Lancet. Oncology.

Oncogenetic tree modeling of human hepatocarcinogenesis

Axel Benner, Kai Breuhahn, Peter Schirmacher, 2012, International journal of cancer.

Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases

Olaf Neumann, Michael Thomas, Ivo Buchhalter, 2019, International journal of cancer.

Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians.

Olaf Neumann, Michael Thomas, Jan Budczies, 2018, Translational lung cancer research.

Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy.

Axel Benner, Birgit Luber, Niels Grabe, 2011, Cancer research.

Expression of the bitter receptor T2R38 in pancreatic cancer: localization in lipid droplets and activation by a bacteria-derived quorum-sensing molecule

Peter Schirmacher, P. Schirmacher, M. Gaida, 2016, Oncotarget.

Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer.

Peter Schirmacher, Helmut Friess, E Helene Sage, 2007, Neoplasia.

NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial

Michael Hummel, Ulrich Lehmann, Nicole Pfarr, 2016, Virchows Archiv.

Genetic changes of non-small cell lung cancer under neoadjuvant therapy

Nicole Pfarr, Volker Endris, Wilko Weichert, 2016, Oncotarget.

Automatic Tumor-Stroma Separation in Fluorescence TMAs Enables the Quantitative High-Throughput Analysis of Multiple Cancer Biomarkers

Bernd Lahrmann, Niels Grabe, Peter Schirmacher, 2011, PloS one.

Methanobactin reverses acute liver failure in a rat model of Wilson disease.

Nathan Bandow, Jerzy Adamski, Ralf Wimmer, 2016, The Journal of clinical investigation.

Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop

Michael Thomas, Federico Cappuzzo, Manfred Dietel, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study.

Jürgen Böhm, Johanna W Lampe, Reka Toth, 2015, The American journal of clinical nutrition.

Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection

Frank Bergmann, Jürgen Debus, Daniel Habermehl, 2013, Radiation oncology.

TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.

Kai Breuhahn, Norbert Gretz, Carsten Sticht, 2020, Cancer letters.